http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004505976-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2001-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2004505976-A |
| titleOfInvention | Variolin B derivative |
| abstract | The present invention provides an anti-tumor compound of formula (I) and pharmaceutically acceptable salts thereof, wherein R 1 is an aromatic substituent; R 2 is hydrogen, or when the dashed line is absent a substituent, or the broken line represents a bond, R 2 is when you give a double bond between the carbon having a nitrogen and R 3 having the R 2 is absent; R 3 is An oxo group ＯO 2 when no dashed line is present, or a substituent when the dashed line represents a bond, giving a double bond between the nitrogen bearing R 2 and the carbon bearing R 3 ; R 4 is hydrogen Or a substituent. |
| priorityDate | 2000-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 221.